Literature DB >> 12505629

Automatic quantitation of HIV-1 mediated cell-to-cell fusion with a digital image analysis system (DIAS): application for rapid screening of HIV-1 fusion inhibitors.

Hong Lu1, Qian Zhao, Zhikai Xu, Shibo Jiang.   

Abstract

Human immunodeficiency viruses type 1 (HIV-1) mediated cell-to-cell fusion plays an important role in HIV-1 spread from infected cells to uninfected cells and in HIV-1 cytopathogenesis. In the present study, we developed a convenient cell fusion assay using a computer-controlled digital image analysis system (DIAS) for automatic quantitation. Compared with a manual quantitative method, DIAS automatic method is less laborious, and more rapid. Furthermore, it is more objective and less dependent on the researchers' experience. This method has great potential to be developed further as a high-throughput screening assay for rapid screening of HIV-1 fusion inhibitors, for evaluating the activity of HIV-1 entry inhibitors and for studying the mechanism of action of anti-HIV-1 agents.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12505629     DOI: 10.1016/s0166-0934(02)00213-6

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  8 in total

1.  N-substituted pyrrole derivatives as novel human immunodeficiency virus type 1 entry inhibitors that interfere with the gp41 six-helix bundle formation and block virus fusion.

Authors:  Shibo Jiang; Hong Lu; Shuwen Liu; Qian Zhao; Yuxian He; Asim K Debnath
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

2.  A novel chimeric protein-based HIV-1 fusion inhibitor targeting gp41 glycoprotein with high potency and stability.

Authors:  Chungen Pan; Lifeng Cai; Hong Lu; Lu Lu; Shibo Jiang
Journal:  J Biol Chem       Date:  2011-06-20       Impact factor: 5.157

3.  Multiparametric assay to screen and dissect the mode of action of anti-human immunodeficiency virus envelope drugs.

Authors:  Julià Blanco; Imma Clotet-Codina; Berta Bosch; Mercedes Armand-Ugón; Bonaventura Clotet; José A Esté
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

4.  Combinations of the first and next generations of human immunodeficiency virus (HIV) fusion inhibitors exhibit a highly potent synergistic effect against enfuvirtide- sensitive and -resistant HIV type 1 strains.

Authors:  Chungen Pan; Lifeng Cai; Hong Lu; Zhi Qi; Shibo Jiang
Journal:  J Virol       Date:  2009-06-03       Impact factor: 5.103

5.  ADS-J1 inhibits human immunodeficiency virus type 1 entry by interacting with the gp41 pocket region and blocking fusion-active gp41 core formation.

Authors:  Hongtao Wang; Zhi Qi; Angi Guo; Qinchao Mao; Hong Lu; Xiuli An; Chenglai Xia; Xiaojuan Li; Asim K Debnath; Shuguang Wu; Shuwen Liu; Shibo Jiang
Journal:  Antimicrob Agents Chemother       Date:  2009-09-28       Impact factor: 5.191

Review 6.  In vitro methods for testing antiviral drugs.

Authors:  Michaela Rumlová; Tomáš Ruml
Journal:  Biotechnol Adv       Date:  2017-12-29       Impact factor: 14.227

7.  A Novel CXCR4 Targeting Protein SDF-1/54 as an HIV-1 Entry Inhibitor.

Authors:  Suiyi Tan; Wenjuan Li; Zhaofeng Li; Yujing Li; Jiangyan Luo; Liangzhentian Yu; Jie Yang; Mengjie Qiu; Hongyan Cheng; Wei Xu; Shibo Jiang; Lu Lu; Shuwen Liu; Weifeng Ma
Journal:  Viruses       Date:  2019-09-18       Impact factor: 5.048

8.  Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor.

Authors:  Lu Lu; Qi Liu; Yun Zhu; Kwok-Hung Chan; Lili Qin; Yuan Li; Qian Wang; Jasper Fuk-Woo Chan; Lanying Du; Fei Yu; Cuiqing Ma; Sheng Ye; Kwok-Yung Yuen; Rongguang Zhang; Shibo Jiang
Journal:  Nat Commun       Date:  2014       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.